Implementation Guide CH VACD
4.0.0-ci-build - ci-build
Implementation Guide CH VACD, published by HL7 Switzerland. This is not an authorized publication; it is the continuous build for version 4.0.0-ci-build). This version is based on the current content of https://github.com/hl7ch/ch-vacd/ and changes regularly. See the Directory of published versions
Official URL: http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-recommendation-forecast-status-cs | Version: 4.0.0-ci-build | |||
Active as of 2023-09-01 | Computable Name: SwissRecommendationForecastStatusCodesystem | |||
Other Identifiers: id: entry-conflict (use: OFFICIAL) | ||||
Copyright/Legal: CC0-1.0 |
Swiss Recommendation Forecast Status Codesystem
This Code system is referenced in the content logical definition of the following value sets:
This case-sensitive code system http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-recommendation-forecast-status-cs
defines the following codes:
Additional Language Displays
Code | Deutsch (Schweiz) (German (Switzerland), de) | English (United States) (English (United States), en) | French (Switzerland) (fr) | Italian (Switzerland) (it) | rm |
due | The patient is due for their next vaccination. | The patient is due for their next vaccination. | The patient is due for their next vaccination. | The patient is due for their next vaccination. | The patient is due for their next vaccination. |
overdue | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. |
immune | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. |
consultadvise | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. |
indicated | The patient is indicated for further doses. | The patient is indicated for further doses. | The patient is indicated for further doses. | The patient is indicated for further doses. | The patient is indicated for further doses. |
contraindicated | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. |
complete | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. |
notrelevant | There is no relevance for this patient. | There is no relevance for this patient. | There is no relevance for this patient. | There is no relevance for this patient. | There is no relevance for this patient. |